Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 6 OF 9 | DISPLAYING 76 - 90 OF 134 RESULTS

    Weiss S.A. et al., Immunologic heterogeneity of tumor infiltrating lymphocyte composition in primary melanoma., [Epub ahead of print]., Human Pathology, Jul 26, 2016

    Zaretsky J.M. et al., Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma., [Epub ahead of print]., NEJM, Jul 13, 2016

    Antonios J.P. et al., PD-1 blockade enhances the vaccination-induced immune response in glioma, [Epub ahead of print]., JCI, Jul 07, 2016

    Armand P. et al., Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure, [Epub ahead of print]., J. Clin. Oncol., Jun 27, 2016

    Herter-Sprie G.S. et al., Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer, [Epub ahead of print]., JCI Insight, Jun 16, 2016

    Chen P.L. et al., Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade., [Epub ahead of print]., Cancer Discovery, Jun 14, 2016

    Mullane S.A. et. al., Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma., [Epub ahead of print]., Sci. Reports, Jun 10, 2016

    Gray M.J. et al., Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers., [Epub ahead of print]., Breast Can Res., May 11, 2016

    De Marco P. et al., GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response., [Epub ahead of print]., Sci. Reports, Apr 13, 2016

    Balko J. et al., Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence., [Epub ahead of print]., Sci. Transl. Med., Apr 13, 2016

    Sterman D.H. et al., PILOT AND FEASIBILITY TRIAL OF IMMUNO-GENE THERAPY OF MALIGNANT MESOTHELIOMA USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA COMBINED WITH CHEMOTHERAPY., [Epub ahead of print]., Clin. Can. Res., Mar 11, 2016

    D'Artista L. et al., Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc., [Epub ahead of print]., Oncotarget, Mar 02, 2016

    Gabrusiewicz K et al., Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype, [Epub ahead of print]., JCI, Feb 25, 2016

    Peng W. et al., Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy., [Epub ahead of print]., Cancer Discovery, Feb 01, 2016

    Kroeger D.R. et al., Tumor infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T cell responses, and superior prognosis in ovarian cancer., [Epub ahead of print]., Clin. Cancer Res., Jan 13, 2016